nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—lung cancer	0.227	0.529	CbGaD
Diflunisal—ALB—lung cancer	0.203	0.471	CbGaD
Diflunisal—ALB—Gefitinib—lung cancer	0.0628	0.214	CbGbCtD
Diflunisal—PTGS2—Cisplatin—lung cancer	0.0434	0.147	CbGbCtD
Diflunisal—PTGS2—Etoposide—lung cancer	0.0426	0.145	CbGbCtD
Diflunisal—ALB—Erlotinib—lung cancer	0.0372	0.126	CbGbCtD
Diflunisal—PTGS1—Etoposide—lung cancer	0.036	0.122	CbGbCtD
Diflunisal—ALB—Irinotecan—lung cancer	0.0336	0.114	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—lung cancer	0.0209	0.0709	CbGbCtD
Diflunisal—ALB—Methotrexate—lung cancer	0.0178	0.0604	CbGbCtD
Diflunisal—Niclosamide—STAT3—lung cancer	0.00282	0.44	CrCbGaD
Diflunisal—Salicylic acid—AKR1C1—lung cancer	0.00146	0.228	CrCbGaD
Diflunisal—Flurbiprofen—UGT1A1—lung cancer	0.000472	0.0739	CrCbGaD
Diflunisal—Olsalazine—PTGS2—lung cancer	0.000283	0.0443	CrCbGaD
Diflunisal—Aminosalicylic Acid—PTGS2—lung cancer	0.000267	0.0417	CrCbGaD
Diflunisal—Salsalate—PTGS2—lung cancer	0.000241	0.0377	CrCbGaD
Diflunisal—Mesalazine—PTGS2—lung cancer	0.000209	0.0327	CrCbGaD
Diflunisal—Headache—Topotecan—lung cancer	0.000178	0.00107	CcSEcCtD
Diflunisal—Rash—Erlotinib—lung cancer	0.000177	0.00107	CcSEcCtD
Diflunisal—Dermatitis—Erlotinib—lung cancer	0.000177	0.00107	CcSEcCtD
Diflunisal—Palpitations—Paclitaxel—lung cancer	0.000177	0.00107	CcSEcCtD
Diflunisal—Insomnia—Gemcitabine—lung cancer	0.000177	0.00106	CcSEcCtD
Diflunisal—Dyspepsia—Irinotecan—lung cancer	0.000177	0.00106	CcSEcCtD
Diflunisal—Headache—Erlotinib—lung cancer	0.000176	0.00106	CcSEcCtD
Diflunisal—Loss of consciousness—Paclitaxel—lung cancer	0.000176	0.00106	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000176	0.00106	CcSEcCtD
Diflunisal—Hyperhidrosis—Cisplatin—lung cancer	0.000176	0.00106	CcSEcCtD
Diflunisal—Paraesthesia—Gemcitabine—lung cancer	0.000175	0.00106	CcSEcCtD
Diflunisal—Asthenia—Vinorelbine—lung cancer	0.000174	0.00105	CcSEcCtD
Diflunisal—Decreased appetite—Irinotecan—lung cancer	0.000174	0.00105	CcSEcCtD
Diflunisal—Dyspnoea—Gemcitabine—lung cancer	0.000174	0.00105	CcSEcCtD
Diflunisal—Chest pain—Etoposide—lung cancer	0.000174	0.00105	CcSEcCtD
Diflunisal—Nausea—Vinblastine—lung cancer	0.000174	0.00105	CcSEcCtD
Diflunisal—Somnolence—Gemcitabine—lung cancer	0.000174	0.00105	CcSEcCtD
Diflunisal—Anorexia—Cisplatin—lung cancer	0.000174	0.00104	CcSEcCtD
Diflunisal—Fatigue—Irinotecan—lung cancer	0.000173	0.00104	CcSEcCtD
Diflunisal—Pruritus—Vinorelbine—lung cancer	0.000172	0.00104	CcSEcCtD
Diflunisal—Constipation—Irinotecan—lung cancer	0.000171	0.00103	CcSEcCtD
Diflunisal—Chest pain—Paclitaxel—lung cancer	0.000171	0.00103	CcSEcCtD
Diflunisal—Decreased appetite—Gemcitabine—lung cancer	0.00017	0.00102	CcSEcCtD
Diflunisal—Nausea—Topotecan—lung cancer	0.000169	0.00102	CcSEcCtD
Diflunisal—Fatigue—Gemcitabine—lung cancer	0.000168	0.00101	CcSEcCtD
Diflunisal—Confusional state—Etoposide—lung cancer	0.000168	0.00101	CcSEcCtD
Diflunisal—Constipation—Gemcitabine—lung cancer	0.000167	0.00101	CcSEcCtD
Diflunisal—Nausea—Erlotinib—lung cancer	0.000167	0.00101	CcSEcCtD
Diflunisal—Anaphylactic shock—Etoposide—lung cancer	0.000167	0.001	CcSEcCtD
Diflunisal—Diarrhoea—Vinorelbine—lung cancer	0.000166	0.001	CcSEcCtD
Diflunisal—Feeling abnormal—Irinotecan—lung cancer	0.000165	0.000995	CcSEcCtD
Diflunisal—Confusional state—Paclitaxel—lung cancer	0.000165	0.000993	CcSEcCtD
Diflunisal—Dysuria—Methotrexate—lung cancer	0.000164	0.000989	CcSEcCtD
Diflunisal—Gastrointestinal pain—Irinotecan—lung cancer	0.000164	0.000987	CcSEcCtD
Diflunisal—Anaphylactic shock—Paclitaxel—lung cancer	0.000164	0.000984	CcSEcCtD
Diflunisal—Oedema—Paclitaxel—lung cancer	0.000164	0.000984	CcSEcCtD
Diflunisal—Paraesthesia—Cisplatin—lung cancer	0.000163	0.000984	CcSEcCtD
Diflunisal—Thrombocytopenia—Etoposide—lung cancer	0.000163	0.000983	CcSEcCtD
Diflunisal—Muscle spasms—Docetaxel—lung cancer	0.000163	0.000983	CcSEcCtD
Diflunisal—Dyspnoea—Cisplatin—lung cancer	0.000162	0.000977	CcSEcCtD
Diflunisal—Hyperhidrosis—Etoposide—lung cancer	0.000161	0.000971	CcSEcCtD
Diflunisal—Feeling abnormal—Gemcitabine—lung cancer	0.000161	0.000969	CcSEcCtD
Diflunisal—Shock—Paclitaxel—lung cancer	0.000161	0.000968	CcSEcCtD
Diflunisal—Dizziness—Vinorelbine—lung cancer	0.000161	0.000968	CcSEcCtD
Diflunisal—Photosensitivity reaction—Methotrexate—lung cancer	0.00016	0.000965	CcSEcCtD
Diflunisal—Thrombocytopenia—Paclitaxel—lung cancer	0.00016	0.000964	CcSEcCtD
Diflunisal—Anorexia—Etoposide—lung cancer	0.000159	0.000957	CcSEcCtD
Diflunisal—Body temperature increased—Irinotecan—lung cancer	0.000159	0.000954	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000159	0.000954	CcSEcCtD
Diflunisal—Decreased appetite—Cisplatin—lung cancer	0.000158	0.000953	CcSEcCtD
Diflunisal—Hyperhidrosis—Paclitaxel—lung cancer	0.000158	0.000952	CcSEcCtD
Diflunisal—Anorexia—Paclitaxel—lung cancer	0.000156	0.000938	CcSEcCtD
Diflunisal—Gastritis—Doxorubicin—lung cancer	0.000156	0.000938	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000155	0.000935	CcSEcCtD
Diflunisal—Vomiting—Vinorelbine—lung cancer	0.000155	0.00093	CcSEcCtD
Diflunisal—Body temperature increased—Gemcitabine—lung cancer	0.000154	0.000929	CcSEcCtD
Diflunisal—Renal failure—Methotrexate—lung cancer	0.000154	0.000927	CcSEcCtD
Diflunisal—Rash—Vinorelbine—lung cancer	0.000153	0.000923	CcSEcCtD
Diflunisal—Dermatitis—Vinorelbine—lung cancer	0.000153	0.000922	CcSEcCtD
Diflunisal—Stomatitis—Methotrexate—lung cancer	0.000153	0.000919	CcSEcCtD
Diflunisal—Headache—Vinorelbine—lung cancer	0.000152	0.000917	CcSEcCtD
Diflunisal—Syncope—Docetaxel—lung cancer	0.000152	0.000917	CcSEcCtD
Diflunisal—Sweating—Methotrexate—lung cancer	0.00015	0.000904	CcSEcCtD
Diflunisal—Palpitations—Docetaxel—lung cancer	0.00015	0.000903	CcSEcCtD
Diflunisal—Feeling abnormal—Cisplatin—lung cancer	0.00015	0.000903	CcSEcCtD
Diflunisal—Paraesthesia—Etoposide—lung cancer	0.00015	0.000901	CcSEcCtD
Diflunisal—Haematuria—Methotrexate—lung cancer	0.000149	0.000899	CcSEcCtD
Diflunisal—Loss of consciousness—Docetaxel—lung cancer	0.000149	0.000899	CcSEcCtD
Diflunisal—Dyspnoea—Etoposide—lung cancer	0.000149	0.000895	CcSEcCtD
Diflunisal—Somnolence—Etoposide—lung cancer	0.000148	0.000892	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—lung cancer	0.000148	0.0232	CrCbGaD
Diflunisal—Insomnia—Paclitaxel—lung cancer	0.000148	0.00089	CcSEcCtD
Diflunisal—Hypersensitivity—Irinotecan—lung cancer	0.000148	0.000889	CcSEcCtD
Diflunisal—Paraesthesia—Paclitaxel—lung cancer	0.000147	0.000884	CcSEcCtD
Diflunisal—Agranulocytosis—Methotrexate—lung cancer	0.000146	0.00088	CcSEcCtD
Diflunisal—Dyspnoea—Paclitaxel—lung cancer	0.000146	0.000878	CcSEcCtD
Diflunisal—Somnolence—Paclitaxel—lung cancer	0.000145	0.000875	CcSEcCtD
Diflunisal—Decreased appetite—Etoposide—lung cancer	0.000145	0.000873	CcSEcCtD
Diflunisal—Chest pain—Docetaxel—lung cancer	0.000145	0.00087	CcSEcCtD
Diflunisal—Nausea—Vinorelbine—lung cancer	0.000144	0.000869	CcSEcCtD
Diflunisal—Dyspepsia—Paclitaxel—lung cancer	0.000144	0.000866	CcSEcCtD
Diflunisal—Body temperature increased—Cisplatin—lung cancer	0.000144	0.000866	CcSEcCtD
Diflunisal—Asthenia—Irinotecan—lung cancer	0.000144	0.000866	CcSEcCtD
Diflunisal—Fatigue—Etoposide—lung cancer	0.000144	0.000866	CcSEcCtD
Diflunisal—Constipation—Etoposide—lung cancer	0.000143	0.000859	CcSEcCtD
Diflunisal—Dysuria—Doxorubicin—lung cancer	0.000142	0.000856	CcSEcCtD
Diflunisal—Decreased appetite—Paclitaxel—lung cancer	0.000142	0.000856	CcSEcCtD
Diflunisal—Fatigue—Paclitaxel—lung cancer	0.000141	0.000849	CcSEcCtD
Diflunisal—Hepatitis—Methotrexate—lung cancer	0.000141	0.000846	CcSEcCtD
Diflunisal—Asthenia—Gemcitabine—lung cancer	0.00014	0.000844	CcSEcCtD
Diflunisal—Constipation—Paclitaxel—lung cancer	0.00014	0.000842	CcSEcCtD
Diflunisal—Confusional state—Docetaxel—lung cancer	0.00014	0.000841	CcSEcCtD
Diflunisal—Photosensitivity reaction—Doxorubicin—lung cancer	0.000139	0.000836	CcSEcCtD
Diflunisal—Anaphylactic shock—Docetaxel—lung cancer	0.000139	0.000834	CcSEcCtD
Diflunisal—Oedema—Docetaxel—lung cancer	0.000139	0.000834	CcSEcCtD
Diflunisal—Pruritus—Gemcitabine—lung cancer	0.000138	0.000832	CcSEcCtD
Diflunisal—Feeling abnormal—Etoposide—lung cancer	0.000137	0.000827	CcSEcCtD
Diflunisal—Diarrhoea—Irinotecan—lung cancer	0.000137	0.000826	CcSEcCtD
Diflunisal—Gastrointestinal pain—Etoposide—lung cancer	0.000136	0.000821	CcSEcCtD
Diflunisal—Shock—Docetaxel—lung cancer	0.000136	0.000821	CcSEcCtD
Diflunisal—Thrombocytopenia—Docetaxel—lung cancer	0.000136	0.000817	CcSEcCtD
Diflunisal—Visual impairment—Methotrexate—lung cancer	0.000136	0.000816	CcSEcCtD
Diflunisal—Feeling abnormal—Paclitaxel—lung cancer	0.000135	0.000811	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000134	0.000809	CcSEcCtD
Diflunisal—Hypersensitivity—Cisplatin—lung cancer	0.000134	0.000807	CcSEcCtD
Diflunisal—Gastrointestinal pain—Paclitaxel—lung cancer	0.000134	0.000805	CcSEcCtD
Diflunisal—Diarrhoea—Gemcitabine—lung cancer	0.000134	0.000804	CcSEcCtD
Diflunisal—Renal failure—Doxorubicin—lung cancer	0.000133	0.000803	CcSEcCtD
Diflunisal—Erythema multiforme—Methotrexate—lung cancer	0.000133	0.0008	CcSEcCtD
Diflunisal—Dizziness—Irinotecan—lung cancer	0.000133	0.000798	CcSEcCtD
Diflunisal—Urticaria—Etoposide—lung cancer	0.000133	0.000798	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—lung cancer	0.000132	0.000796	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—lung cancer	0.000132	0.000796	CcSEcCtD
Diflunisal—Anorexia—Docetaxel—lung cancer	0.000132	0.000795	CcSEcCtD
Diflunisal—Salicylic acid—ALB—lung cancer	0.000132	0.0207	CrCbGaD
Diflunisal—Body temperature increased—Etoposide—lung cancer	0.000132	0.000794	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—lung cancer	0.000131	0.000789	CcSEcCtD
Diflunisal—Asthenia—Cisplatin—lung cancer	0.000131	0.000786	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—lung cancer	0.00013	0.000783	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—lung cancer	0.00013	0.0203	CrCbGaD
Diflunisal—Urticaria—Paclitaxel—lung cancer	0.00013	0.000782	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—lung cancer	0.000129	0.000778	CcSEcCtD
Diflunisal—Body temperature increased—Paclitaxel—lung cancer	0.000129	0.000778	CcSEcCtD
Diflunisal—Vomiting—Irinotecan—lung cancer	0.000128	0.000767	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—lung cancer	0.000127	0.000762	CcSEcCtD
Diflunisal—Rash—Irinotecan—lung cancer	0.000126	0.000761	CcSEcCtD
Diflunisal—Dermatitis—Irinotecan—lung cancer	0.000126	0.00076	CcSEcCtD
Diflunisal—Salicylic acid—ABCB1—lung cancer	0.000126	0.0197	CrCbGaD
Diflunisal—Headache—Irinotecan—lung cancer	0.000126	0.000756	CcSEcCtD
Diflunisal—Insomnia—Docetaxel—lung cancer	0.000125	0.000755	CcSEcCtD
Diflunisal—Diarrhoea—Cisplatin—lung cancer	0.000125	0.00075	CcSEcCtD
Diflunisal—Paraesthesia—Docetaxel—lung cancer	0.000124	0.000749	CcSEcCtD
Diflunisal—Vomiting—Gemcitabine—lung cancer	0.000124	0.000748	CcSEcCtD
Diflunisal—Dyspnoea—Docetaxel—lung cancer	0.000124	0.000744	CcSEcCtD
Diflunisal—Somnolence—Docetaxel—lung cancer	0.000123	0.000742	CcSEcCtD
Diflunisal—Rash—Gemcitabine—lung cancer	0.000123	0.000741	CcSEcCtD
Diflunisal—Dermatitis—Gemcitabine—lung cancer	0.000123	0.000741	CcSEcCtD
Diflunisal—Hypersensitivity—Etoposide—lung cancer	0.000123	0.00074	CcSEcCtD
Diflunisal—Headache—Gemcitabine—lung cancer	0.000122	0.000737	CcSEcCtD
Diflunisal—Dyspepsia—Docetaxel—lung cancer	0.000122	0.000734	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—lung cancer	0.000122	0.000733	CcSEcCtD
Diflunisal—Decreased appetite—Docetaxel—lung cancer	0.000121	0.000725	CcSEcCtD
Diflunisal—Hypersensitivity—Paclitaxel—lung cancer	0.00012	0.000725	CcSEcCtD
Diflunisal—Asthenia—Etoposide—lung cancer	0.00012	0.00072	CcSEcCtD
Diflunisal—Fatigue—Docetaxel—lung cancer	0.00012	0.000719	CcSEcCtD
Diflunisal—Nausea—Irinotecan—lung cancer	0.000119	0.000717	CcSEcCtD
Diflunisal—Constipation—Docetaxel—lung cancer	0.000119	0.000713	CcSEcCtD
Diflunisal—Pruritus—Etoposide—lung cancer	0.000118	0.00071	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—lung cancer	0.000117	0.000706	CcSEcCtD
Diflunisal—Asthenia—Paclitaxel—lung cancer	0.000117	0.000706	CcSEcCtD
Diflunisal—Nausea—Gemcitabine—lung cancer	0.000116	0.000698	CcSEcCtD
Diflunisal—Flurbiprofen—ALB—lung cancer	0.000116	0.0181	CrCbGaD
Diflunisal—Vomiting—Cisplatin—lung cancer	0.000116	0.000697	CcSEcCtD
Diflunisal—Pruritus—Paclitaxel—lung cancer	0.000116	0.000696	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—lung cancer	0.000115	0.000694	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—lung cancer	0.000115	0.000693	CcSEcCtD
Diflunisal—Rash—Cisplatin—lung cancer	0.000115	0.000691	CcSEcCtD
Diflunisal—Dermatitis—Cisplatin—lung cancer	0.000115	0.00069	CcSEcCtD
Diflunisal—Feeling abnormal—Docetaxel—lung cancer	0.000114	0.000688	CcSEcCtD
Diflunisal—Diarrhoea—Etoposide—lung cancer	0.000114	0.000687	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—lung cancer	0.000114	0.000683	CcSEcCtD
Diflunisal—Gastrointestinal pain—Docetaxel—lung cancer	0.000113	0.000682	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—lung cancer	0.000113	0.00068	CcSEcCtD
Diflunisal—Diarrhoea—Paclitaxel—lung cancer	0.000112	0.000673	CcSEcCtD
Diflunisal—Dizziness—Etoposide—lung cancer	0.00011	0.000664	CcSEcCtD
Diflunisal—Vertigo—Methotrexate—lung cancer	0.00011	0.000662	CcSEcCtD
Diflunisal—Body temperature increased—Docetaxel—lung cancer	0.00011	0.00066	CcSEcCtD
Diflunisal—Dizziness—Paclitaxel—lung cancer	0.000108	0.000651	CcSEcCtD
Diflunisal—Nausea—Cisplatin—lung cancer	0.000108	0.000651	CcSEcCtD
Diflunisal—Vomiting—Etoposide—lung cancer	0.000106	0.000638	CcSEcCtD
Diflunisal—Rash—Etoposide—lung cancer	0.000105	0.000633	CcSEcCtD
Diflunisal—Dermatitis—Etoposide—lung cancer	0.000105	0.000632	CcSEcCtD
Diflunisal—Headache—Etoposide—lung cancer	0.000104	0.000629	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—lung cancer	0.000104	0.000629	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—lung cancer	0.000104	0.000627	CcSEcCtD
Diflunisal—Tension—Doxorubicin—lung cancer	0.000104	0.000626	CcSEcCtD
Diflunisal—Vomiting—Paclitaxel—lung cancer	0.000104	0.000626	CcSEcCtD
Diflunisal—Rash—Paclitaxel—lung cancer	0.000103	0.000621	CcSEcCtD
Diflunisal—Dermatitis—Paclitaxel—lung cancer	0.000103	0.00062	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—lung cancer	0.000103	0.00062	CcSEcCtD
Diflunisal—Headache—Paclitaxel—lung cancer	0.000102	0.000617	CcSEcCtD
Diflunisal—Hypersensitivity—Docetaxel—lung cancer	0.000102	0.000615	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—lung cancer	0.000102	0.000613	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—lung cancer	0.000101	0.000606	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—lung cancer	9.99e-05	0.000601	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—lung cancer	9.99e-05	0.000601	CcSEcCtD
Diflunisal—Asthenia—Docetaxel—lung cancer	9.95e-05	0.000599	CcSEcCtD
Diflunisal—Nausea—Etoposide—lung cancer	9.91e-05	0.000596	CcSEcCtD
Diflunisal—Pruritus—Docetaxel—lung cancer	9.81e-05	0.00059	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—lung cancer	9.78e-05	0.000589	CcSEcCtD
Diflunisal—Nausea—Paclitaxel—lung cancer	9.71e-05	0.000585	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—lung cancer	9.66e-05	0.000581	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—lung cancer	9.52e-05	0.000573	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—lung cancer	9.52e-05	0.000573	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—lung cancer	9.51e-05	0.000572	CcSEcCtD
Diflunisal—Diarrhoea—Docetaxel—lung cancer	9.49e-05	0.000571	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—lung cancer	9.37e-05	0.000564	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—lung cancer	9.32e-05	0.000561	CcSEcCtD
Diflunisal—Dizziness—Docetaxel—lung cancer	9.17e-05	0.000552	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—lung cancer	9.04e-05	0.000544	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—lung cancer	9.03e-05	0.000543	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—lung cancer	8.97e-05	0.00054	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—lung cancer	8.91e-05	0.000536	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—lung cancer	8.88e-05	0.000535	CcSEcCtD
Diflunisal—Vomiting—Docetaxel—lung cancer	8.81e-05	0.00053	CcSEcCtD
Diflunisal—Dyspepsia—Methotrexate—lung cancer	8.8e-05	0.000529	CcSEcCtD
Diflunisal—Rash—Docetaxel—lung cancer	8.74e-05	0.000526	CcSEcCtD
Diflunisal—Dermatitis—Docetaxel—lung cancer	8.73e-05	0.000526	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—lung cancer	8.72e-05	0.000525	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—lung cancer	8.69e-05	0.000523	CcSEcCtD
Diflunisal—Headache—Docetaxel—lung cancer	8.68e-05	0.000523	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—lung cancer	8.65e-05	0.000521	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—lung cancer	8.65e-05	0.000521	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—lung cancer	8.61e-05	0.000518	CcSEcCtD
Diflunisal—Shock—Doxorubicin—lung cancer	8.51e-05	0.000512	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—lung cancer	8.47e-05	0.00051	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—lung cancer	8.36e-05	0.000503	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—lung cancer	8.25e-05	0.000496	CcSEcCtD
Diflunisal—Nausea—Docetaxel—lung cancer	8.23e-05	0.000496	CcSEcCtD
Diflunisal—Feeling abnormal—Methotrexate—lung cancer	8.23e-05	0.000496	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—lung cancer	8.17e-05	0.000492	CcSEcCtD
Diflunisal—Urticaria—Methotrexate—lung cancer	7.94e-05	0.000478	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—lung cancer	7.9e-05	0.000475	CcSEcCtD
Diflunisal—Insomnia—Doxorubicin—lung cancer	7.83e-05	0.000471	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—lung cancer	7.77e-05	0.000468	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—lung cancer	7.71e-05	0.000464	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—lung cancer	7.69e-05	0.000463	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—lung cancer	7.62e-05	0.000458	CcSEcCtD
Diflunisal—Decreased appetite—Doxorubicin—lung cancer	7.52e-05	0.000453	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—lung cancer	7.46e-05	0.000449	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—lung cancer	7.4e-05	0.000445	CcSEcCtD
Diflunisal—Hypersensitivity—Methotrexate—lung cancer	7.36e-05	0.000443	CcSEcCtD
Diflunisal—Asthenia—Methotrexate—lung cancer	7.17e-05	0.000431	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—lung cancer	7.13e-05	0.000429	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—lung cancer	7.07e-05	0.000426	CcSEcCtD
Diflunisal—Pruritus—Methotrexate—lung cancer	7.07e-05	0.000425	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—lung cancer	6.87e-05	0.000414	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—lung cancer	6.84e-05	0.000412	CcSEcCtD
Diflunisal—Diarrhoea—Methotrexate—lung cancer	6.84e-05	0.000411	CcSEcCtD
Diflunisal—Dizziness—Methotrexate—lung cancer	6.61e-05	0.000398	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—lung cancer	6.37e-05	0.000384	CcSEcCtD
Diflunisal—Vomiting—Methotrexate—lung cancer	6.35e-05	0.000382	CcSEcCtD
Diflunisal—Rash—Methotrexate—lung cancer	6.3e-05	0.000379	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—lung cancer	6.29e-05	0.000379	CcSEcCtD
Diflunisal—Headache—Methotrexate—lung cancer	6.26e-05	0.000377	CcSEcCtD
Diflunisal—Asthenia—Doxorubicin—lung cancer	6.21e-05	0.000374	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—lung cancer	6.12e-05	0.000368	CcSEcCtD
Diflunisal—Nausea—Methotrexate—lung cancer	5.93e-05	0.000357	CcSEcCtD
Diflunisal—Diarrhoea—Doxorubicin—lung cancer	5.92e-05	0.000356	CcSEcCtD
Diflunisal—Dizziness—Doxorubicin—lung cancer	5.72e-05	0.000344	CcSEcCtD
Diflunisal—Vomiting—Doxorubicin—lung cancer	5.5e-05	0.000331	CcSEcCtD
Diflunisal—Rash—Doxorubicin—lung cancer	5.46e-05	0.000328	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—lung cancer	5.45e-05	0.000328	CcSEcCtD
Diflunisal—Headache—Doxorubicin—lung cancer	5.42e-05	0.000326	CcSEcCtD
Diflunisal—Nausea—Doxorubicin—lung cancer	5.14e-05	0.000309	CcSEcCtD
Diflunisal—TTR—Signaling Pathways—CREBBP—lung cancer	2.02e-05	0.000196	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GCLC—lung cancer	2.02e-05	0.000195	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP2A6—lung cancer	2.02e-05	0.000195	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.01e-05	0.000195	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	2e-05	0.000194	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ENO2—lung cancer	2e-05	0.000193	CbGpPWpGaD
Diflunisal—ALB—Metabolism—RRM1—lung cancer	1.99e-05	0.000193	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTA3—lung cancer	1.99e-05	0.000193	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PPP2R1B—lung cancer	1.98e-05	0.000192	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SMARCA4—lung cancer	1.98e-05	0.000192	CbGpPWpGaD
Diflunisal—TTR—Disease—EP300—lung cancer	1.97e-05	0.000191	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—UGT1A1—lung cancer	1.97e-05	0.00019	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAP2K1—lung cancer	1.93e-05	0.000187	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.93e-05	0.000186	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CD—lung cancer	1.92e-05	0.000186	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ENO1—lung cancer	1.91e-05	0.000185	CbGpPWpGaD
Diflunisal—TTR—Disease—SRC—lung cancer	1.91e-05	0.000185	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.91e-05	0.000185	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—AVP—lung cancer	1.9e-05	0.000184	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GNG11—lung cancer	1.9e-05	0.000184	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.89e-05	0.000183	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.88e-05	0.000182	CbGpPWpGaD
Diflunisal—ALB—Metabolism—B4GALT5—lung cancer	1.87e-05	0.000181	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.86e-05	0.00018	CbGpPWpGaD
Diflunisal—TTR—Disease—STAT3—lung cancer	1.85e-05	0.000179	CbGpPWpGaD
Diflunisal—TTR—Disease—NRAS—lung cancer	1.84e-05	0.000178	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	1.84e-05	0.000178	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	1.82e-05	0.000176	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTA4—lung cancer	1.82e-05	0.000176	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ENO1—lung cancer	1.81e-05	0.000176	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALDOA—lung cancer	1.81e-05	0.000175	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.78e-05	0.000172	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	1.78e-05	0.000172	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTA2—lung cancer	1.77e-05	0.000172	CbGpPWpGaD
Diflunisal—TTR—Disease—MAPK3—lung cancer	1.76e-05	0.000171	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NCOA3—lung cancer	1.75e-05	0.00017	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MMP1—lung cancer	1.75e-05	0.00017	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.72e-05	0.000167	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MDM2—lung cancer	1.72e-05	0.000166	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP2E1—lung cancer	1.72e-05	0.000166	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—lung cancer	1.72e-05	0.000166	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RAF1—lung cancer	1.71e-05	0.000166	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CA—lung cancer	1.71e-05	0.000166	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTA1—lung cancer	1.71e-05	0.000166	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ADCY1—lung cancer	1.7e-05	0.000165	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ABCG2—lung cancer	1.7e-05	0.000165	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NQO1—lung cancer	1.7e-05	0.000164	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ERBB2—lung cancer	1.69e-05	0.000164	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCC3—lung cancer	1.69e-05	0.000164	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APP—lung cancer	1.69e-05	0.000163	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	1.68e-05	0.000163	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—lung cancer	1.68e-05	0.000162	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—APOA1—lung cancer	1.68e-05	0.000162	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGF9—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CB—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MTOR—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ENO2—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—HPGDS—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.66e-05	0.000161	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPP2R1B—lung cancer	1.66e-05	0.000161	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.65e-05	0.000159	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.64e-05	0.000159	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AKR1C1—lung cancer	1.64e-05	0.000159	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTT1—lung cancer	1.62e-05	0.000157	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL8—lung cancer	1.61e-05	0.000156	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP2A6—lung cancer	1.6e-05	0.000155	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GCLC—lung cancer	1.6e-05	0.000155	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JUNB—lung cancer	1.6e-05	0.000155	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.6e-05	0.000155	CbGpPWpGaD
Diflunisal—ALB—Metabolism—UGT1A1—lung cancer	1.59e-05	0.000154	CbGpPWpGaD
Diflunisal—TTR—Disease—KRAS—lung cancer	1.58e-05	0.000153	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.57e-05	0.000152	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CASP3—lung cancer	1.54e-05	0.000149	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—lung cancer	1.54e-05	0.000149	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GNG11—lung cancer	1.53e-05	0.000148	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CG—lung cancer	1.53e-05	0.000148	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—STK11—lung cancer	1.53e-05	0.000148	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.53e-05	0.000148	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ENO1—lung cancer	1.52e-05	0.000147	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.51e-05	0.000147	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—EGF—lung cancer	1.51e-05	0.000146	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—lung cancer	1.5e-05	0.000145	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.49e-05	0.000145	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JUN—lung cancer	1.49e-05	0.000145	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ALDOA—lung cancer	1.46e-05	0.000141	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CA—lung cancer	1.46e-05	0.000141	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—lung cancer	1.45e-05	0.000141	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.45e-05	0.00014	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1A—lung cancer	1.45e-05	0.00014	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTEN—lung cancer	1.45e-05	0.00014	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.44e-05	0.000139	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CREBBP—lung cancer	1.42e-05	0.000137	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NCOA3—lung cancer	1.42e-05	0.000137	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTP1—lung cancer	1.42e-05	0.000137	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FOXO3—lung cancer	1.4e-05	0.000136	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—AKT1—lung cancer	1.4e-05	0.000135	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.39e-05	0.000135	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.39e-05	0.000134	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ADCY1—lung cancer	1.38e-05	0.000134	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCG2—lung cancer	1.38e-05	0.000134	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EP300—lung cancer	1.38e-05	0.000133	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CAT—lung cancer	1.38e-05	0.000133	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.37e-05	0.000133	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP2E1—lung cancer	1.36e-05	0.000132	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HPGDS—lung cancer	1.35e-05	0.000131	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ENO2—lung cancer	1.35e-05	0.000131	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NQO1—lung cancer	1.35e-05	0.00013	CbGpPWpGaD
Diflunisal—TTR—Disease—HRAS—lung cancer	1.35e-05	0.00013	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CD—lung cancer	1.35e-05	0.00013	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPP2R1B—lung cancer	1.34e-05	0.00013	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SRC—lung cancer	1.34e-05	0.00013	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ABCB1—lung cancer	1.34e-05	0.00013	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.33e-05	0.000128	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.32e-05	0.000128	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TYMS—lung cancer	1.32e-05	0.000127	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTT1—lung cancer	1.31e-05	0.000127	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—lung cancer	1.31e-05	0.000126	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTM1—lung cancer	1.3e-05	0.000126	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP2A6—lung cancer	1.3e-05	0.000126	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GCLC—lung cancer	1.3e-05	0.000126	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—lung cancer	1.29e-05	0.000125	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.29e-05	0.000125	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NRAS—lung cancer	1.29e-05	0.000125	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—lung cancer	1.29e-05	0.000125	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HES1—lung cancer	1.24e-05	0.00012	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK3—lung cancer	1.23e-05	0.00012	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1A1—lung cancer	1.23e-05	0.000119	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ENO1—lung cancer	1.23e-05	0.000119	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	1.23e-05	0.000119	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.22e-05	0.000119	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ERCC2—lung cancer	1.22e-05	0.000118	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—STK11—lung cancer	1.21e-05	0.000118	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RAF1—lung cancer	1.2e-05	0.000116	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—lung cancer	1.2e-05	0.000116	CbGpPWpGaD
Diflunisal—TTR—Disease—AKT1—lung cancer	1.19e-05	0.000115	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—lung cancer	1.17e-05	0.000114	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CB—lung cancer	1.17e-05	0.000114	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERCC2—lung cancer	1.16e-05	0.000112	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.14e-05	0.00011	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB3—lung cancer	1.13e-05	0.00011	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	1.13e-05	0.00011	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTP1—lung cancer	1.12e-05	0.000109	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KRAS—lung cancer	1.11e-05	0.000107	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP2E1—lung cancer	1.1e-05	0.000107	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CAT—lung cancer	1.09e-05	0.000106	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NQO1—lung cancer	1.09e-05	0.000106	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.09e-05	0.000105	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TERT—lung cancer	1.09e-05	0.000105	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—lung cancer	1.08e-05	0.000104	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.07e-05	0.000103	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ABCB1—lung cancer	1.06e-05	0.000103	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—APOA1—lung cancer	1.06e-05	0.000102	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.06e-05	0.000102	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGFR1—lung cancer	1.06e-05	0.000102	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TYMS—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HIF1A—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTM1—lung cancer	1.03e-05	0.0001	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CA—lung cancer	1.02e-05	9.87e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.01e-05	9.81e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APOA1—lung cancer	1e-05	9.71e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—lung cancer	9.86e-06	9.55e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—STK11—lung cancer	9.83e-06	9.51e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1A1—lung cancer	9.79e-06	9.48e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ERCC2—lung cancer	9.71e-06	9.4e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—EP300—lung cancer	9.66e-06	9.35e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CG—lung cancer	9.66e-06	9.35e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HRAS—lung cancer	9.43e-06	9.13e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SRC—lung cancer	9.4e-06	9.1e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.23e-06	8.93e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—POMC—lung cancer	9.2e-06	8.9e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KIT—lung cancer	9.16e-06	8.86e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APC—lung cancer	9.16e-06	8.86e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—lung cancer	9.15e-06	8.86e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTP1—lung cancer	9.09e-06	8.8e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGF—lung cancer	9.05e-06	8.76e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NRAS—lung cancer	9.04e-06	8.75e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—lung cancer	9.03e-06	8.74e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CREBBP—lung cancer	8.96e-06	8.67e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CAT—lung cancer	8.85e-06	8.57e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.8e-06	8.52e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK3—lung cancer	8.66e-06	8.38e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—BRAF—lung cancer	8.61e-06	8.33e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCB1—lung cancer	8.61e-06	8.33e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6R—lung cancer	8.5e-06	8.23e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CD—lung cancer	8.49e-06	8.22e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CREBBP—lung cancer	8.49e-06	8.22e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TYMS—lung cancer	8.45e-06	8.18e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—APOA1—lung cancer	8.4e-06	8.13e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALB—lung cancer	8.38e-06	8.12e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTM1—lung cancer	8.36e-06	8.09e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AKT1—lung cancer	8.33e-06	8.06e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAP2K1—lung cancer	8.1e-06	7.84e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CD—lung cancer	8.05e-06	7.79e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.04e-06	7.79e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1A1—lung cancer	7.92e-06	7.67e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ERCC2—lung cancer	7.86e-06	7.61e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—KRAS—lung cancer	7.78e-06	7.53e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CG—lung cancer	7.67e-06	7.42e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CB—lung cancer	7.4e-06	7.17e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—lung cancer	7.34e-06	7.1e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—POMC—lung cancer	7.3e-06	7.07e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MDM2—lung cancer	7.21e-06	6.98e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RAF1—lung cancer	7.19e-06	6.96e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CA—lung cancer	7.15e-06	6.92e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CREBBP—lung cancer	7.11e-06	6.88e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB2—lung cancer	7.11e-06	6.88e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MTOR—lung cancer	7.02e-06	6.79e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CB—lung cancer	7.02e-06	6.79e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD4—lung cancer	7e-06	6.78e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—lung cancer	6.92e-06	6.69e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—APOA1—lung cancer	6.8e-06	6.58e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CD—lung cancer	6.74e-06	6.53e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALB—lung cancer	6.66e-06	6.44e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—HRAS—lung cancer	6.61e-06	6.4e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.51e-06	6.3e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTEN—lung cancer	6.4e-06	6.19e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CG—lung cancer	6.21e-06	6.01e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—EP300—lung cancer	6.1e-06	5.91e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1A—lung cancer	6.08e-06	5.88e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PTEN—lung cancer	6.06e-06	5.87e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—POMC—lung cancer	5.91e-06	5.72e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CB—lung cancer	5.88e-06	5.69e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—AKT1—lung cancer	5.84e-06	5.65e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EP300—lung cancer	5.78e-06	5.6e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CREBBP—lung cancer	5.75e-06	5.57e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SRC—lung cancer	5.62e-06	5.44e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CD—lung cancer	5.45e-06	5.28e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—lung cancer	5.42e-06	5.25e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NRAS—lung cancer	5.41e-06	5.24e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAPK3—lung cancer	5.18e-06	5.02e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTEN—lung cancer	5.08e-06	4.92e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—lung cancer	5.04e-06	4.88e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—lung cancer	4.93e-06	4.77e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—EP300—lung cancer	4.84e-06	4.69e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CB—lung cancer	4.75e-06	4.6e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—lung cancer	4.71e-06	4.56e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KRAS—lung cancer	4.66e-06	4.51e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CA—lung cancer	4.51e-06	4.37e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CA—lung cancer	4.28e-06	4.14e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTEN—lung cancer	4.11e-06	3.98e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HRAS—lung cancer	3.96e-06	3.83e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—EP300—lung cancer	3.92e-06	3.79e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—lung cancer	3.79e-06	3.67e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AKT1—lung cancer	3.69e-06	3.57e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CA—lung cancer	3.58e-06	3.47e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—AKT1—lung cancer	3.49e-06	3.38e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AKT1—lung cancer	2.93e-06	2.83e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CA—lung cancer	2.9e-06	2.81e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AKT1—lung cancer	2.37e-06	2.29e-05	CbGpPWpGaD
